NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 19:43:39 GMT 2025` Edited by `admin` on `Tue Apr 01 19:43:39 GMT 2025`
Protein Type	KINASE
Protein Sub Type	TYROSINE KINASE
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	V094BEF0W8
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2

Common Name

English

TYK2

Preferred Name

English

Code System Code Type Description

SMS_ID

100000177932

Created by admin on Tue Apr 01 19:43:39 GMT 2025 , Edited by admin on Tue Apr 01 19:43:39 GMT 2025

PRIMARY

PHAROS

P29597

Created by admin on Tue Apr 01 19:43:39 GMT 2025 , Edited by admin on Tue Apr 01 19:43:39 GMT 2025

PRIMARY

FDA UNII

V094BEF0W8

Created by admin on Tue Apr 01 19:43:39 GMT 2025 , Edited by admin on Tue Apr 01 19:43:39 GMT 2025

PRIMARY

UNIPROT

P29597

Created by admin on Tue Apr 01 19:43:39 GMT 2025 , Edited by admin on Tue Apr 01 19:43:39 GMT 2025

PRIMARY

Related Record Type Details


					4MO0WIY820

JAK-IN-28

INHIBITOR -> TARGET

Amount:


					N0A21N6RAU

DEUCRAVACITINIB

INHIBITOR -> TARGET

Comments:

Tyk2 JH2 ligand

Qualification:

IC50

Amount:


					86YZ7HCC8V

PF-06263276

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					3XVL385Q0M

FILGOTINIB

WEAK INHIBITOR->TARGETF

Qualification:

IC50

Amount:


					HPH1166CKX

PEFICITINIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					HPH1166CKX

PEFICITINIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					3X8387Q25N

BREPOCITINIB

INHIBITOR -> TARGET


					6L1XP550I6

FEDRATINIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					J2Q5XQZ64C

BMS-986202

INHIBITOR -> TARGET

Comments:

TYK2 JH2 LIGAND

Qualification:

Ki

Amount:


					82S8X8XX8H

Ruxolitinib

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					4RA0KN46E0

UPADACITINIB

WEAK INHIBITOR->OFF TARGET

Qualification:

IC50

Amount:


					9L0Q8KK220

Delgocitinib

WEAK INHIBITOR->TARGET

Qualification:

IC50

Amount:


					3V7GQ1260K

SOLCITINIB

WEAK INHIBITOR->TARGET

Amount:


					3V7GQ1260K

SOLCITINIB

WEAK INHIBITOR->TARGETF

Qualification:

IC50

Amount:


					G22N65IL3O

PACRITINIB

INHIBITOR -> TARGET

Amount:


					87LA6FU830

Tofacitinib

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					6O01GMS00P

MOMELOTINIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					19J3781LPM

ITACITINIB

WEAK INHIBITOR->TARGETF

Qualification:

IC50

Amount:


					ISP4442I3Y

BARICITINIB

INHIBITOR -> TARGET

Amount:


					DBA7WU5NH4

TUL-01101

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					3X8387Q25N

BREPOCITINIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					JAC34RRR7S

Londamocitinib

WEAK INHIBITOR->TARGET

Qualification:

IC50

Amount:


					73SM5SF3OR

ABROCITINIB

WEAK INHIBITOR->OFF TARGET

Qualification:

IC50

Amount:


					4801QYW816

GUSACITINIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					2OYE00PC25

RITLECITINIB

NON-INHIBITOR->OFF-TARGET

Qualification:

IC50

Amount:


					HY5SOV7O0Q

ROPSACITINIB

TARGET -> INHIBITOR

Qualification:

IC50

Amount:


					HY5SOV7O0Q

ROPSACITINIB

INHIBITOR -> TARGET

Comments:

JH1 Binding site

Qualification:

Kd

Amount:


					2ZT81PV5UM

IZENCITINIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					D1LXQ45S1O

CERDULATINIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					C293MNS6TQ

Zasocitinib

INHIBITOR -> TARGET

Interaction Type:

IN-VITRO

Amount:

Structural Modifications

Modification Type	Location Site	Fragment Name	Fragment Approval
AMINO ACID SUBSTITUTION	[1_1054]	TYROSINE O-PHOSPHATE	2R86C98KDX
AMINO ACID SUBSTITUTION	[1_292] [1_604]	TYROSINE O-PHOSPHATE	2R86C98KDX
AMINO ACID SUBSTITUTION	[1_525] [1_884]	DEXFOSFOSERINE	VI4F0K069V

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT	CHEMICAL